AP-MS with VAR2CSA and oncofetal chondroitin sulfate antibodies

ABSTRACT: Tumors display oncofetal chondroitin sulfate (ofCS) glycosaminoglycans that support disease progression and dissemination. ofCS can be detected by the the Plasmodium falciparum derived VAR2CSA protein but the development of recombinant VAR2CSA as a clinical tool has proven challenging. Here, we performed AP-MS experiments with newly developed antibodies with ofCS specificity comparable to VAR2CSA, as well as recombinant VAR2CSA bait.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Osteosarcoma Cell Line, Colon, Prostate Cancer Cell Line, Colonic Adenocarcinoma Cell Line, Choriocarcinoma Cell Line

DISEASE(S): Cancer

SUBMITTER: Michael Wierer  

LAB HEAD: Ali Salanti

PROVIDER: PXD044455 | Pride | 2024-08-31

REPOSITORIES: Pride